Regulation of epidermal growth factor receptor in NIH3T3/HER14 cells by antireceptor monoclonal antibodies.

[1]  J. Baselga,et al.  Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha. , 1992, Cancer research.

[2]  S. Hirono,et al.  Effects of protein kinase inhibitors on the mitogenic activity of human hepatocyte growth factor on rat hepatocytes in primary culture. , 1992, Biochemical and biophysical research communications.

[3]  E. Lapetina,et al.  Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells. , 1992, The Journal of biological chemistry.

[4]  W. Karnes,et al.  Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody. , 1992, Gastroenterology.

[5]  M. Reiss,et al.  Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells. , 1991, Cancer research.

[6]  J. Mendelsohn,et al.  Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. , 1991, Cancer research.

[7]  R. Kumar,et al.  Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. , 1991, The Journal of biological chemistry.

[8]  A. Ullrich,et al.  A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization , 1991, Molecular and cellular biology.

[9]  J. Boonstra,et al.  Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. , 1991, The Journal of biological chemistry.

[10]  T Pawson,et al.  Src homology region 2 domains direct protein-protein interactions in signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Boonstra,et al.  Antibody-induced activation of the epidermal growth factor receptor tyrosine kinase requires the presence of detergent. , 1990, Biochemical and biophysical research communications.

[12]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[13]  B. Margolis,et al.  The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation. , 1990, The Biochemical journal.

[14]  J. Mendelsohn,et al.  Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody , 1990, Journal of cellular physiology.

[15]  A. Ullrich,et al.  Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor , 1990, Molecular and cellular biology.

[16]  S. Bates,et al.  Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. , 1989, Molecular endocrinology.

[17]  R. W. Baldwin,et al.  Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments. , 1989, Journal of immunological methods.

[18]  M. Sela,et al.  Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. , 1988, Journal of the National Cancer Institute.

[19]  C. Osborne,et al.  Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer. , 1988, Molecular endocrinology.

[20]  A. Ullrich,et al.  Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Ullrich,et al.  A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis , 1987, Molecular and cellular biology.

[22]  A. Ullrich,et al.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing , 1987, Cell.

[23]  M. Herlyn,et al.  Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. , 1987, Cancer research.

[24]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[25]  Y. Yarden,et al.  Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. , 1987, Biochemistry.

[26]  C. Mummery,et al.  Antireceptor antibodies in the study of EGF-receptor interaction. , 1987, Cell differentiation.

[27]  L. Defize,et al.  Dissociation of cellular responses to epidermal growth factor using anti‐receptor monoclonal antibodies. , 1986, The EMBO journal.

[28]  C. Macleod,et al.  Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Macleod,et al.  A direct radioimmunoassay for human epidermal growth factor receptor using 32P-autophosphorylated receptor. , 1985, Analytical biochemistry.

[30]  J. A. Fernandez-Pol.  Epidermal growth factor receptor of A431 cells. Characterization of a monoclonal anti-receptor antibody noncompetitive agonist of epidermal growth factor action. , 1985, The Journal of biological chemistry.

[31]  A. Ullrich,et al.  Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbb protein , 1985, Cell.

[32]  J. Mendelsohn,et al.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.

[33]  J. Mendelsohn,et al.  Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. , 1984, The Journal of biological chemistry.

[34]  P. Parham.  On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. , 1983, Journal of immunology.

[35]  H. Earp,et al.  Solubilization of EGF receptor with Triton X-100 alters stimulation of tyrosine residue phosphorylation by EGF and dimethyl sulfoxide. , 1983, The Journal of biological chemistry.

[36]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Libermann,et al.  Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. , 1983, The Journal of biological chemistry.

[38]  O. Wieland,et al.  Phosphorylation—dephosphorylation of purified insulin receptor from human placenta , 1982, FEBS letters.

[39]  C. Heldin,et al.  Characterization of a tyrosine-specific kinase activity in human fibroblast membranes stimulated by platelet-derived growth factor. , 1982, The Journal of biological chemistry.

[40]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[41]  G. Carpenter,et al.  Receptors for epidermal growth factor and other polypeptide mitogens. , 1987, Annual review of biochemistry.

[42]  P. Goodfellow,et al.  A monoclonal antibody to the human epidermal growth factor receptor , 1982, Journal of cellular biochemistry.